NCT00191893View on ClinicalTrials.gov

Bone Effects of Teriparatide Following Alendronate

PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

November 30, 2006

Conditions
Osteoporosis
Interventions
DRUG

teriparatide

Trial Locations (2)

12808

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Prague

A-8010

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Graz

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00191893 - Bone Effects of Teriparatide Following Alendronate | Biotech Hunter | Biotech Hunter